DN1508052-01 / Shanghai De Novo Pharmatech - LARVOL DELTA

A Study to Evaluate the Safety, Tolerability of DN1508052-01 in Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=19 | Completed | Sponsor: Shanghai De Novo Pharmatech Co., Ltd. | Unknown status ➔ Completed | Trial completion date: Aug 2021 ➔ Oct 2022 | Trial primary completion date: Aug 2020 ➔ Aug 2022

Trial completion • Trial completion date • Trial primary completion date • Oncology • Solid Tumor

A Study to Evaluate the Safety, Tolerability of DN1508052-01 to Advanced Solid Tumors (clinicaltrials.gov) - P1; N=25; Recruiting; Sponsor: Shanghai De Novo Pharmatech Co., Ltd.; Not yet recruiting ➔ Recruiting; Initiation date: May 2019 ➔ Sep 2019

Clinical • Enrollment open • Trial initiation date